|
1
|
Sakuragi N: Up-to-date management of lymph
node metastasis and the role of tailored lymphadenectomy in
cervical cancer. Int J Clin Oncol. 12:165–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Selman TJ, Luesley DM, Murphy DJ and Mann
CH: Is radical hysterectomy for early stage cervical cancer an
outdated operation? BJOG. 112:363–365. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Monteil J, Maubon A, Leobon S, et al:
Lymph node assessment with (18)F-FDG-PET and MRI in uterine
cervical cancer. Anticancer Res. 31:3865–3871. 2011.PubMed/NCBI
|
|
4
|
van Kouwenhove M, Kedde M and Agami R:
MicroRNA regulation by RNA-binding proteins and its implications
for cancer. Nat Rev Cancer. 11:644–656. 2011.PubMed/NCBI
|
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ceppi P, Mudduluru G, Kumarswamy R, Rapa
I, Scagliotti GV, Papotti M and Allgayer H: Loss of miR-200c
expression induces an aggressive, invasive, and chemoresistant
phenotype in non-small cell lung cancer. Mol Cancer Res.
8:1207–1216. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q
and Xu K: MiR-26a enhances metastasis potential of lung cancer
cells via AKT pathway by targeting PTEN. Biochim Biophys Acta.
1822:1692–1704. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng B, Liang L, Wang C, et al:
MicroRNA-148a suppresses tumor cell invasion and metastasis by
downregulating ROCK1 in gastric cancer. Clin Cancer Res.
17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pereira PM, Marques JP, Soares AR, Carreto
L and Santos MA: MicroRNA expression variability in human cervical
tissues. PLoS One. 5:e117802010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JW, Choi CH, Choi JJ, et al: Altered
microRNA expression in cervical carcinomas. Clin Cancer Res.
14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan Y, Luo YC, Wan HY, et al: MicroRNA-10a
is involved in the metastatic process by regulating Eph tyrosine
kinase receptor A4-mediated epithelial-mesenchymal transition and
adhesion in hepatoma cells. Hepatology. 57:667–677. 2013.
View Article : Google Scholar
|
|
12
|
Chen W, Tang Z, Sun Y, et al: miRNA
expression profile in primary gastric cancers and paired lymph node
metastases indicates that miR-10a plays a role in metastasis from
primary gastric cancer to lymph nodes. Exp Ther Med. 3:351–356.
2012.
|
|
13
|
Markou A, Sourvinou I, Vorkas PA, Yousef
GM and Lianidou E: Clinical evaluation of microRNA expression
profiling in non small cell lung cancer. Lung Cancer. 81:388–396.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsushima K, Isomoto H, Kohno S and Nakao
K: MicroRNAs and esophageal squamous cell carcinoma. Digestion.
82:138–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gouy S, Morice P, Narducci F, et al:
Nodal-staging surgery for locally advanced cervical cancer in the
era of PET. Lancet Oncol. 13:e212–e220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kato T, Watari H, Takeda M, et al:
Multivariate prognostic analysis of adenocarcinoma of the uterine
cervix treated with radical hysterectomy and systematic
lymphadenectomy. J Gynecol Oncol. 24:222–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He L, Thomson JM, Hemann MT, et al: A
microRNA polycistron as a potential human oncogene. Nature.
435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang H, Li Y and Lai M: The microRNA
network and tumor metastasis. Oncogene. 29:937–948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen W, Cai F, Zhang B, Barekati Z and
Zhong XY: The level of circulating miRNA-10b and miRNA-373 in
detecting lymph node metastasis of breast cancer: potential
biomarkers. Tumour Biol. 34:455–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu Y, Sun J, Xu J, Li Q, Guo Y and Zhang
Q: miR-21 is a promising novel biomarker for lymph node metastasis
in patients with gastric cancer. Gastroenterol Res Pract.
2012:6401682012.PubMed/NCBI
|
|
21
|
Wu WY, Xue XY, Chen ZJ, et al: Potentially
predictive microRNAs of gastric cancer with metastasis to lymph
node. World J Gastroenterol. 17:3645–3651. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao S, Yao D, Chen J and Ding N:
Circulating miRNA-20a and miRNA-203 for screening lymph node
metastasis in early stage cervical cancer. Genet Test Mol
Biomarkers. 17:631–636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lund AH: miR-10 in development and cancer.
Cell Death Differ. 17:209–214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ørom UA, Nielsen FC and Lund AH:
MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and
enhances their translation. Mol Cell. 30:460–471. 2008.PubMed/NCBI
|
|
25
|
Gaur A, Jewell DA, Liang Y, et al:
Characterization of microRNA expression levels and their biological
correlates in human cancer cell lines. Cancer Res. 67:2456–2468.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Varnholt H, Drebber U, Schulze F, et al:
MicroRNA gene expression profile of hepatitis C virus-associated
hepatocellular carcinoma. Hepatology. 47:1223–1232. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garzon R, Garofalo M, Martelli MP, et al:
Distinctive microRNA signature of acute myeloid leukemia bearing
cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA.
105:3945–3950. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kotelevets L, van Hengel J, Bruyneel E,
Mareel M, van Roy F and Chastre E: The lipid phosphatase activity
of PTEN is critical for stabilizing intercellular junctions and
reverting invasiveness. J Cell Biol. 155:1129–1135. 2001.
View Article : Google Scholar
|
|
30
|
Li J, Yen C, Liaw D, et al: PTEN, a
putative protein tyrosine phosphatase gene mutated in human brain,
breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tamura M, Gu J, Matsumoto K, Aota S,
Parsons R and Yamada KM: Inhibition of cell migration, spreading,
and focal adhesions by tumor suppressor PTEN. Science.
280:1614–1617. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carracedo A, Alimonti A and Pandolfi PP:
PTEN level in tumor suppression: how much is too little? Cancer
Res. 71:629–633. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eijsink JJ, Noordhuis MG, ten Hoor KA, et
al: The epidermal growth factor receptor pathway in relation to
pelvic lymph node metastasis and survival in early-stage cervical
cancer. Hum Pathol. 41:1735–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu D, Qian J, Yin X, Xiao Q, Wang C and
Zeng Y: Expression of PTEN and survivin in cervical cancer:
promising biological markers for early diagnosis and prognostic
evaluation. Br J Biomed Sci. 69:143–146. 2012.PubMed/NCBI
|
|
35
|
Zhu L, Loo WT and Louis WC: PTEN and VEGF:
possible predictors for sentinel lymph node micro-metastasis in
breast cancer. Biomed Pharmacother. 61:558–561. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ettl T, Gosau M, Brockhoff G, et al:
Predictors of cervical lymph node metastasis in salivary gland
cancer. Head Neck. 36:517–523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Damsky WE, Curley DP, Santhanakrishnan M,
et al: Beta-catenin signaling controls metastasis in Braf-activated
Pten-deficient melanomas. Cancer Cell. 20:741–754. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Persad S, Troussard AA, McPhee TR,
Mulholland DJ and Dedhar S: Tumor suppressor PTEN inhibits nuclear
accumulation of beta-catenin and T cell/lymphoid enhancer factor
1-mediated transcriptional activation. J Cell Biol. 153:1161–1174.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jamieson C, Sharma M and Henderson BR: Wnt
signaling from membrane to nucleus: beta-catenin caught in a loop.
Int J Biochem Cell Biol. 44:847–850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Giangreco A, Lu L, Vickers C, et al:
Beta-Catenin determines upper airway progenitor cell fate and
preinvasive squamous lung cancer progression by modulating
epithelial-mesenchymal transition. J Pathol. 226:575–587. 2012.
View Article : Google Scholar
|
|
41
|
Noordhuis MG, Fehrmann RS, Wisman GB, et
al: Involvement of the TGF-beta and beta-catenin pathways in pelvic
lymph node metastasis in early-stage cervical cancer. Clin Cancer
Res. 17:1317–1330. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li XQ, Yang XL, Zhang G, et al: Nuclear
β-catenin accumulation is associated with increased expression of
Nanog protein and predicts poor prognosis of non-small cell lung
cancer. J Transl Med. 11:1142013.
|
|
43
|
Ramachandran I, Thavathiru E, Ramalingam
S, et al: Wnt inhibitory factor 1 induces apoptosis and inhibits
cervical cancer growth, invasion and angiogenesis in vivo.
Oncogene. 31:2725–2737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Heuberger J and Birchmeier W: Interplay of
cadherin-mediated cell adhesion and canonical Wnt signaling. Cold
Spring Harb Perspect Biol. 2:a0029152010. View Article : Google Scholar : PubMed/NCBI
|
